Matthews Andrea
SEC insider (Form 3/4/5 filer). CIK 0001973349. Chief Business Officer at Astria Therapeutics, Inc. (ATXS). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 23, 2026. Located in BOSTON, MA.
Companies Matthews Andrea has filed insider reports for
- Astria Therapeutics, Inc. (ATXS): Officer, Chief Business Officer
Matthews Andrea
CIK: 0001973349
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Astria Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
32.8K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
20K shares- - Jan 23, 2026ATXS
Astria Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
262.5K shares- - Mar 21, 2025ATXS
Astria Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
262.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 32,812 | - | - | Direct |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 20,000 | - | - | Direct |
| Jan 23, 2026 | ATXS Astria Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 262,500 | - | - | Direct |
| Mar 21, 2025 | ATXS Astria Therapeutics, Inc. | Award Stock Option (Right to Buy) | 262,500 | - | - | Direct |
1-4 of 4 transactions